NCT03438669
- Conditions
- Eye Diseases, Macular Degeneration, Retinal Degeneration, +1 more
- Locations
-
- Vista Klinik Binningen, Basel-Landschaft, Switzerland
Clinical trial condition
Retinal Diseases
Explore clinical trials studying Retinal Diseases. Study availability and eligibility vary by location and protocol.
2,349 public trials
291 recruiting studies
Retinal Diseases trial results
NCT02249897
- Conditions
- Cardiovascular Diseases, Diabetes, Diabetes Complications, +15 more
- Locations
-
- Institute of Nutrition & Food Technology (INTA) Santiago, Metropolitan Region, Chile
- Clinica Alemana de Santiago Santiago, Santiago Metropolitan, Chile
NCT02859766
- Conditions
- Eye Diseases, Macular Degeneration, Retinal Degeneration, +1 more
- Locations
-
- Retinal Consultants of Arizona Gilbert, Arizona, United States
- Win Retina Arcadia, California, United States
- Retina Vitreous Associates Medical Group Beverly Hills, California, United States
- Atlantis Retina Institute (Atlantis Eyecare) Huntington Beach, California, United States
Completed
SD-OCT-guided Intravitreal Ranibizumab Treatment in Choroidal Neovascularization Due to Myopia
NCT03409250
- Conditions
- Age Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +9 more
- Locations
-
- Vista Klinik Binningen, Basel-Landschaft, Switzerland
NCT02805686
- Conditions
- Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Eye Diseases, +4 more
- Locations
-
Not specified
NCT02762188
- Conditions
- Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +2 more
- Locations
-
- CHU Brugmann Brussels, Belgium
NCT03404323
- Conditions
- Cataract, Epiretinal Membrane, Eye Diseases, +7 more
- Locations
-
Not specified
Completed
First-In-Human Clinical Study of the C3 Complement Inhibitor AMY- 101 in Healthy Male Volunteers
NCT03316521
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +12 more
- Locations
-
- HighPoint Clinical Trials Center High Point, North Carolina, United States
NCT01837121
- Conditions
- Behavior, Cardiovascular Diseases, Compliance, +14 more
- Locations
-
- Blindness Preventment and Treatment Department, Zhongshan Ophthalmic Center Guangzhou, Guangdong, China
Completed
Phase I RVC With Ocriplasmin for CRVO
NCT02747030
- Conditions
- Cardiovascular Diseases, Central Retinal Vein Occlusion, Embolism and Thrombosis, +6 more
- Locations
-
- UZ Leuven Leuven, Vlaams Brabant, Belgium